How To Choose Microfiltration Or Ultrafiltration membranes cassettes?

Apr 30, 2026|

Microfiltration (MF) - Precise particulate control for biopharma processes

Microfiltration membranes with 0.1–0.5 µm pores to remove suspended solids, sediments and larger microorganisms, delivering clear, low-turbidity process streams. In biopharmaceutical manufacturing MF is ideal for:

  • Clarifying cell culture supernatant and fermentation broths
  • Protecting downstream equipment by reducing particulate load and fouling
  • Acting as a primary barrier in water-for-process and utility water systems

 

Key benefits: high throughput, low operating pressure, extended life of downstream membranes. Note: MF does not remove dissolved salts, low‑molecular‑weight organics or reliably clear viruses-use as part of a multi‑stage purification train.

 

Ultrafiltration (UF) - Concentration and fine‑particle removal with molecular selectivity

Ultrafiltration features tighter pores (~0.01–0.1 µm; MWCO expressed in kDa) to retain bacteria, colloids and larger biomolecules. UF is commonly used for:

  • Protein concentration and buffer exchange (diafiltration)
  • Advanced clarification of fermentation and cell culture effluents
  • Reducing colloidal and high‑molecular‑weight impurities prior to final purification
  • Supporting virus‑reduction workflows when combined with validated virus‑removal filters

Key benefits: effective macromolecule retention, scalable flux rates, lower energy compared with RO. UF complements-rather than replaces-validated sterilizing or virus‑removal steps.

 

Why integrate MF and UF in biopharma plants?

  • Optimized multi-stage protection: MF reduces solids load and protects UF/sterilizing filters, improving uptime and lowering lifecycle cost.
  • GMP and validation readiness: membranes available in pharmacopeia‑grade materials that support CIP/SIP, integrity testing and routine process validation.
  • Flexible deployment: scalable modules for pilot to commercial production, compatible with protein, vaccine and sterile drug processes.
  • Regulatory & operational highlights

 

Choose membrane materials and configurations that support CIP/SIP and validated integrity tests.

Implement routine microbial, endotoxin and integrity monitoring to meet GMP expectations.

Use MF/UF as part of a validated, multi‑barrier strategy for product safety and process robustness.

Get started

 

Talk to our filtration specialists to design an MF/UF solution tailored to your biopharma application-clarification, concentration, or upstream/downstream protection.

Send Inquiry